SCHEMBL3785402

SCHEMBL3785402

Nc1cccc(-c2cccc(N)c2Oc2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.53
MAOA P21397 2/20 0.48
MAPT P10636 3/20 0.44
POLB P06746 1/20 0.44
HSP90AA1 P07900 1/20 0.44
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
MAP4K4 O95819 1/20 0.42
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 1/20 0.41
KIT P10721 1/20 0.40
BTK Q06187 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MECP2 P51608 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
ATAD2 Q6PL18 1/20 0.39
TNK2 Q07912 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5745573 0.92 ALDH1A1 (0.45) MAOBMAOAMAPTPOLBHSP90AA1
SCHEMBL25135314 0.90 MAOB (0.58) MAOBMAOAMAPTPOLBHSP90AA1
SCHEMBL3786852 0.88 ALDH1A1 (0.54) MAOBMAOAMAPTPOLBNCOA1
SCHEMBL30822034 0.88 ALDH1A1 (0.54) MAOBMAOAMAPTPOLBNCOA1
SCHEMBL3806719 0.83 NCOA1 (0.53) MAOBMAOAMAPTPOLBNCOA1
SCHEMBL25135313 0.83 NCOA1 (0.62) MAOBMAOAMAPTPOLBNCOA1
SCHEMBL3791439 0.80 NCOA1 (0.67) MAOBMAOAMAPTNCOA1NCOA3
SCHEMBL3786946 0.79 ALDH1A1 (0.52) MAOBMAOAMAPTPOLBNCOA1
SCHEMBL3785574 0.78 FYN (0.54) MAOAMAPTPOLBMAP4K4ALDH1A1
SCHEMBL3789237 0.77 MAOB (0.62) MAOBMAOAMAPTPOLBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAOB 101/4885MAOA 348/4885MAPT 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.